Clene Operating Margin from 2010 to 2024
| CLNNW Stock | USD 0.04 0.01 18.85% |
Check Clene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clene's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 1.5 M or Interest Expense of 4.8 M, as well as many indicators such as Price To Sales Ratio of 45.2, Dividend Yield of 0.0 or PTB Ratio of 2.21. Clene financial statements analysis is a perfect complement when working with Clene Valuation or Volatility modules.
Clene | Operating Margin |
Latest Clene's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Clene Inc over the last few years. It is Clene's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Clene's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (81.22) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Clene Operating Margin Regression Statistics
| Arithmetic Mean | (79.57) | |
| Coefficient Of Variation | (11.48) | |
| Mean Deviation | 6.53 | |
| Median | (82.54) | |
| Standard Deviation | 9.13 | |
| Sample Variance | 83.42 | |
| Range | 33.8473 | |
| R-Value | 0.45 | |
| Mean Square Error | 71.44 | |
| R-Squared | 0.20 | |
| Significance | 0.09 | |
| Slope | 0.92 | |
| Total Sum of Squares | 1,168 |
Clene Operating Margin History
About Clene Financial Statements
Clene investors use historical fundamental indicators, such as Clene's Operating Margin, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Clene. Please read more on our technical analysis and fundamental analysis pages.
Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of various therapeutics for neurodegenerative diseases. The companys products also include CNM-AgZn17, a topical gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to accelerate wound healing and NM-PtAu7, a gold-platinum CSN therapeutic. Clene Inc is traded on NASDAQ Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Clene Stock Analysis
When running Clene's price analysis, check to measure Clene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clene is operating at the current time. Most of Clene's value examination focuses on studying past and present price action to predict the probability of Clene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clene's price. Additionally, you may evaluate how the addition of Clene to your portfolios can decrease your overall portfolio volatility.